Literature DB >> 27477214

Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.

T Sudjaritruk1,2,3, T Bunupuradah3, L Aurpibul4, P Kosalaraksa5, N Kurniati6, W Prasitsuebsai3, J Sophonphan3, A H Sohn7, J Ananworanich8, T Puthanakit3,9.   

Abstract

OBJECTIVES: This study aimed to determine the prevalence of low bone mass and assess its relationship with abnormal bone turnover among HIV-infected Asian adolescents.
METHODS: A multicentre, cross-sectional study was conducted at four paediatric HIV centres in Thailand and Indonesia. Perinatally HIV-infected adolescents aged 10-18 years receiving antiretroviral therapy (ART) with virological suppression (HIV RNA < 400 copies/mL) were enrolled. Study assessments included lumbar spine (L2-L4) dual-energy X-ray absorptiometry and measurement of bone turnover markers. Bone mineral density (BMD) and bone mineral apparent density (BMAD) Z-scores were calculated based on Thai normative age- and sex-matched references. Low bone mass was defined as BMD or BMAD Z-scores ≤ -2.
RESULTS: Of 396 participants, 57% were female. The median age was 15.0 [interquartile range (IQR) 13.3-16.9] years, and 73% were in Tanner stage 3-5. At enrolment, the median CD4 T-cell count was 734 (IQR 581-907) cells/μL, and 37% were on protease inhibitor (PI)-based regimens. The overall prevalence of lumbar spine BMD and BMAD Z-scores ≤ -2 were 16.4% and 8.3%, respectively. Z-scores were lower with older age, female sex, body mass index (BMI) <5th percentile, boosted PI exposure and CD4 T-cell percentage < 15% before ART initiation. Increased bone turnover markers were inversely associated with BMD and BMAD Z-scores.
CONCLUSIONS: Low bone mass was linked to older age, female sex, low BMI, boosted PI exposure, and poor immunological status before ART commencement in our cohort of perinatally HIV-infected Asian adolescents. Dysregulation of bone turnover was associated with bone demineralization. Screening for low bone mass should be implemented to identify individuals who might benefit from interventions to preserve bone health.
© 2016 British HIV Association.

Entities:  

Keywords:  bone mass; bone mineral density; bone remodelling; dual energy X-ray absorptiometry; perinatal HIV infection

Mesh:

Substances:

Year:  2016        PMID: 27477214     DOI: 10.1111/hiv.12418

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  11 in total

1.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

Review 2.  Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings.

Authors:  Steve Innes; Kunjal Patel
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

Review 3.  Growth and pubertal development in HIV-infected adolescents.

Authors:  Paige L Williams; Julie Jesson
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

4.  Fractures in children and adolescents living with perinatally acquired HIV.

Authors:  Denise L Jacobson; Wendy Yu; Rohan Hazra; Sean Brummel; Mitchell E Geffner; Kunjal Patel; William Borkowsky; Jiajia Wang; Janet S Chen; Ayesha Mirza; Linda A DiMeglio
Journal:  Bone       Date:  2020-06-30       Impact factor: 4.398

Review 5.  A review of transition experiences in perinatally and behaviourally acquired HIV-1 infection; same, same but different?

Authors:  Phung Khanh Lam; Sarah Fidler; Caroline Foster
Journal:  J Int AIDS Soc       Date:  2017-05-16       Impact factor: 5.396

6.  Decreased bone turnover in HIV-infected children on antiretroviral therapy.

Authors:  Stephanie Shiau; Michael T Yin; Renate Strehlau; Faeezah Patel; Ndileka Mbete; Louise Kuhn; Ashraf Coovadia; Stephen M Arpadi
Journal:  Arch Osteoporos       Date:  2018-04-05       Impact factor: 2.617

7.  Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients.

Authors:  D Donà; E Mozzo; D Luise; R Lundin; A Padoan; O Rampon; C Giaquinto
Journal:  J Osteoporos       Date:  2019-01-01

8.  Deficits in Bone Architecture and Strength in Children Living With HIV on Antiretroviral Therapy.

Authors:  Stephanie Shiau; Michael T Yin; Renate Strehlau; Megan Burke; Faeezah Patel; Louise Kuhn; Ashraf Coovadia; Shane A Norris; Stephen M Arpadi
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.731

9.  Persistently lower bone mass and bone turnover among South African children living with well controlled HIV.

Authors:  Yanhan Shen; Stephanie Shiau; Renate Strehlau; Megan Burke; Faeezah Patel; Cara T Johnson; Bridgette Rizkalla; Gallagher Dympna; Louise Kuhn; Ashraf Coovadia; Michael T Yin; Stephen M Arpadi
Journal:  AIDS       Date:  2021-11-01       Impact factor: 4.632

10.  Bone mineral density optimisation in adults with perinatally acquired HIV infection in routine care.

Authors:  Thomas J Pasvol; Fred Fyles; Caroline Foster; Sarah Fidler
Journal:  J Virus Erad       Date:  2017-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.